Navigation Links
Top-line Data Show AcelRx Pharmaceuticals' ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
Date:4/24/2013

ARX-04 may ultimately be proven beneficial in a variety of medically supervised settings, including use in battlefield casualty treatment, by paramedics during patient transport, in the emergency room, for non-surgical patients experiencing pain in the hospital, or for post-operative patients, following either short-stay or ambulatory surgery, who do not require more long-term patient-controlled analgesia (PCA).  According to the Centers for Disease Control and Prevention data, there are more than 45 million injury-related emergency department visits and 43 million ambulatory surgery procedures annually in the United States.

About Acute Pain

In situations of trauma or injury, it is advantageous to have a rapid-acting, non-invasive method of treating acute pain. In the battlefield, in the emergency room and in ambulatory care environments, patients often do not have immediate intravenous, or IV, access available. Intramuscular injections are the current standard of care on the battlefield, but they are invasive, painful, and present an increased risk of infection to both patient and healthcare professional.  In addition, in cases of severe trauma where the patient is often in hypovolemic shock and muscles are not well perfused, pain medication given by intramuscular injection may not readily reach the blood stream to provide pain relief, rendering this route of delivery suboptimal.  Oral pills and liquids generally have slow and erratic onset of analgesia.  Even patients with IV access may have undesirable side effects with the commonly used IV opioids morphine and hydromorphone, such as sedation or oxygen desaturation.  Moreover, IV dosing results in high peak plasma levels, thereby limiting the opioid dose and requiring frequent redosing intervals to titrate to satisfactory analgesia.  Additional treatment options are needed which can safely and rapidly treat acute pain, in both civilian and mil
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
2. AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
5. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
6. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
7. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
8. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
9. Top-line Data From Phase 3 Trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis Show Promising Results
10. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... IAP310 study have been published in Regional ... journal with broad, multidisciplinary readership. IAP310 was a ... and efficacy of Zalviso, also referred to as ... treatment of post-operative pain in patients following open ...
(Date:10/20/2014)... 2014  PneumRx, Inc. ( www.pneumrx.com ), a leader ... of enrollment in their RENEW Study, nearly 3 months ... FDA-approved IDE pivotal trial for the PneumRx RePneu Coil ... was anticipated that the study, which began enrolling subjects ... the end of 2014 to enroll 315 patients.  Instead, ...
(Date:10/20/2014)... Oct. 20, 2014  ResMed (NYSE: ... ResMed Data Exchange program, a comprehensive suite of ... (HME) and other health care providers. ... to critical patient information. It integrates valuable sleep ... U-Sleep™ patient management platforms with customers, in-house or ...
Breaking Medicine Technology:AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3ResMed Launches ResMed Data Exchange 2
... 1, 2011  Assembly Bill 5502-B—transmitted to Governor Andrew ... prescriptions in New York by 10 percent, according ... the Bill would prohibit consumers from getting discounted ... Federal Trade Commission warns that AB 5502-B ...
... 1, 2011  Walmart (NYSE: WMT ) announced ... Walmart and Sam,s Club pharmacies immediately for patients with ... name drug better known as Lipitor® provides a more affordable ... to lower their cholesterol due to heart disease or ...
Cached Medicine Technology:NY Pharmacy Bill Sent to Governor Would Raise Drug Prices 2NY Pharmacy Bill Sent to Governor Would Raise Drug Prices 3Walmart Announces Generic Lipitor® (Atorvastatin Calcium Tablets) Available in Stores Today 2
(Date:10/22/2014)... News) -- The United States is now mandating ... of West Africa land at one of five ... the virus. In a statement released Tuesday, ... percent of air passengers from Guinea, Liberia and ... five airports -- New York City,s Kennedy International ...
(Date:10/22/2014)... D.C. (PRWEB) October 22, 2014 With the ... a national survey by the American Institutes for Research (AIR) ... know how to use health insurance, but 42 percent say ... a plan’s details before signing up for coverage. , The ... with only 20 percent able to calculate correctly how much ...
(Date:10/22/2014)... October 22, 2014 Losing Weight Your Body’s ... is staring you in the face, it certainly can be ... do your body an extra favor by doing it the ... crash diets. Instead, listen to your body, exercise regularly, and ... is essential to losing weight; you need to exercise more ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately ... bacterial infections, microbial biofilms, and chronic wounds, announced that ... directors. , Dr. Sinskey is a ... Institute of Technology, or MIT. He has been a ... also holds positions as Co-Director of the Malaysia-MIT Biotechnology ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter , ... young adult men may lead to increased blood pressure, according ... a similar rise in blood pressure for young adult women ... young adult women drank lightly or moderately, their risk of ... "This finding parallels studies in older adult men and ...
Breaking Medicine News(10 mins):Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4
... report issued today identifies the enormous global impact of preterm birth ... estimated 13 million babies are born preterm each year. Newborn deaths ... under the age of five, a rise from 37 percent in ... each year, and many of these losses are linked to maternal ...
... , ... ... ... ...
... , ... International, Inc. has announced its official launch. , ... Anaheim, CA (Vocus) February 18, 2010 -- After a ... official launch. The pilot ramp-up period was designed to simultaneously test its first product ...
... ... ... ... ...
... ... ... ... ...
... limited to physical function but also extend to neurological function, ... Journals of Gerontology Series A: Biological and Medical Sciences ... a collection of ten articles highlighting new findings related to ... consequences of improved medical management of cardiovascular disease is that ...
Cached Medicine News:Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 2Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 3Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 4Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 5Health News:GREENGUARD Environmental Institute Revamps Web Site 2Health News:GREENGUARD Environmental Institute Revamps Web Site 3Health News:GREENGUARD Environmental Institute Revamps Web Site 4Health News:GREENGUARD Environmental Institute Revamps Web Site 5Health News:GREENGUARD Environmental Institute Revamps Web Site 6Health News:GREENGUARD Environmental Institute Revamps Web Site 7Health News:National Launch of Jusuru International 2Health News:National Launch of Jusuru International 3Health News:ATR: The Individual Mandate Excise Tax is a Tax 2Health News:ATR: The Individual Mandate Excise Tax is a Tax 3Health News:ATR: The Individual Mandate Excise Tax is a Tax 4Health News:ATR: The Individual Mandate Excise Tax is a Tax 5Health News:Brookdale Announces New Corporate Line of Credit 2Health News:Brookdale Announces New Corporate Line of Credit 3Health News:Brookdale Announces New Corporate Line of Credit 4Health News:Brookdale Announces New Corporate Line of Credit 5Health News:Overweight middle-aged adults at greater risk for cognitive decline in later life 2
... II system is the Cambridge ... Alternans (MTWA) testing platform which ... cardiac death risk stratification. This ... as it can be configured ...
... incorporate 3 mirrors angled at 76°, 66° and ... chamber as well as central and peripheral fundus ... are accurately angled and spaced 120° apart to ... central portion of the lens also provides direct ...
... provides the highest magnification of ANY gonioscopy lens ... the trabecular meshwork. One 62° mirror presents ... while the central portion of the lens can ... signs of glaucoma and other central retinal maladies. ...
... ultra-clear Volk 3-Mirror optics, incorporating 3 mirrors ... The 3 Mirror is ideal for ... fundus viewing and treatment. The retinal viewing ... in the visualized fundus. The central portion ...
Medicine Products: